HRT Financial's 10.9% passive stake is a significant ownership position for a micro-cap company. Monitor for any future amendments or changes in filing status (e.g., conversion to 13D) if HRT's investment strategy shifts. The passive certification limits near-term activist pressure.
BIAF drugs
BIAF drug pipeline →Price Chart
How similar events traded
Executive Summary
HRT Financial LP disclosed a 10.9% passive stake in bioAffinity Technologies via Schedule 13G, holding 127,132 shares (including 986 shares from warrants). The filing certifies no intent to influence control. The stake is large relative to the company's $4M market cap, but the filing is neutral as it reflects a passive investment position.
Key Financial Metrics
Key Facts
- HRT Financial LP disclosed beneficial ownership of 127,132 shares of bioAffinity Technologies common stock, representing 10.9% of shares outstanding as of September 30, 2026.
- The stake includes 126,146 shares held directly and 986 shares issuable upon exercise of warrants.
- The filing is made under Rule 13d-1(b), certifying passive investment intent with no purpose of changing or influencing control.
- The percentage is based on 1,166,625 shares outstanding as of September 30, 2026, plus 986 warrant shares, for a denominator of 1,167,611 shares.
- HRT Financial LP is a Delaware limited partnership, a quantitative trading firm (Hudson River Trading affiliate).
Financial Impact
10.9% stake in a company with $4M market cap; stake value approximately $436K based on market cap.
Risk Factors
- Passive 13G status could be converted to 13D if HRT later engages with management or seeks board representation.
- The company's small market cap ($4M) and declining revenue (Q3 2026 revenue down 26% YoY) make it vulnerable to dilution or cash burn, which could affect HRT's stake value.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| SC 13G Filing (Primary) | 0001475597-26-000255 |
| Document: 0001475597-26-000255-index.html | 0001475597-26-000255 |
| Document: 0001475597-26-000255.txt | 0001475597-26-000255 |
Track record
37 reports on BIAF
4 of 6 bullish or bearish reports moved the stock their way by T+60. Best: +66.50% at T+60 after the Jul 31, 2026 report. 12 of 16 went positive at some point.
Filters
- Nov 19, 20262d ago SC 13G Neutral 4/10 Viewing Entry $2.01 Now $1.65 −17.91% settles Feb 19
- Nov 19, 20262d ago Insider Buy Bullish 5/10 Entry $2.01 Now $1.65 −17.91% settles Feb 19
- Nov 19, 20262d ago 3 Neutral 3/10 Entry $1.85 Now $1.65 −10.81% settles Feb 18
- Nov 19, 20262d ago 8-K Neutral 2/10 Entry $1.85 Now $1.65 −10.81% settles Feb 18
- Nov 17, 20264d ago 8-K Neutral 3/10 Entry $1.93 Now $1.65 −14.51% settles Feb 16
- Nov 6, 202615d ago 8-K Bearish 5/10 Entry $2.26 Now $1.65 +26.99% settles Feb 5
- Nov 3, 202618d ago 424B5 Bearish 6/10 Entry $2.93 Now $1.65 +43.69% settles Feb 2
- Nov 2, 202619d ago 424B5 Bearish 5/10 Entry $3.19 Now $1.65 +48.28% settles Feb 1
- Oct 29, 202623d ago 8-K Neutral 2/10 Entry $3.03 Now $1.65 −45.54% settles Jan 27
- Oct 23, 202629d ago DEF 14A Neutral 5/10 Entry $2.83 Now $1.65 −41.70% settles Jan 22
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers